Loss of tapasin in human lung and colon cancer cells and escape from tumor-associated antigen-specific CTL recognition

HLA class I is most tightly linked to levels of tapasin compared with other antigen-processing proteins in glioblastoma

(2015) Camilla Thuring et al.   BRITISH JOURNAL OF CANCER

Multiple Structural and Epigenetic Defects in the Human Leukocyte Antigen Class I Antigen Presentation Pathway in a Recurrent Metastatic Melanoma Following Immunotherapy

(2015) Chien-Chung Chang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Loss of tapasin correlates with diminished CD8+ T-cell immunity and prognosis in colorectal cancer

(2015) Lena Sokol et al.   Journal of Translational Medicine

Nivolumab in Previously Untreated Melanoma without BRAF Mutation

(2015) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

(2015) Julie Brahmer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

(2015) Robert J. Motzer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neoantigens in cancer immunotherapy

(2015) T. N. Schumacher et al.   SCIENCE

Tapasin and Human Leukocyte Antigen Class I Dysregulation Correlates with Survival in Glioblastoma Multiforme

(2014) Camilla Thuring et al.   Anti-Cancer Agents in Medicinal Chemistry

Pathways of Antigen Processing

(2013) Janice S. Blum et al.   Annual Review of Immunology

Monitoring peptide processing for MHC class I molecules in the endoplasmic reticulum

(2013) Nilabh Shastri et al.   CURRENT OPINION IN IMMUNOLOGY

ERAAP and Tapasin Independently Edit the Amino and Carboxyl Termini of MHC Class I Peptides

(2013) T. Kanaseki et al.   JOURNAL OF IMMUNOLOGY

RNA-Guided Human Genome Engineering via Cas9

(2013) P. Mali et al.   SCIENCE

Peptidases trimming MHC class I ligands

(2012) Mirjana Weimershaus et al.   CURRENT OPINION IN IMMUNOLOGY

Identification of an alternate splice form of tapasin in human melanoma

(2010) Alan Belicha-Villanueva et al.   HUMAN IMMUNOLOGY

Downregulation of tapasin expression in primary human oral squamous cell carcinoma: association with clinical outcome

(2010) Qian Jiang et al.   TUMOR BIOLOGY

Proteases in MHC Class I Presentation and Cross-Presentation

(2009) Kenneth L. Rock et al.   JOURNAL OF IMMUNOLOGY

Cep55/c10orf3, a Tumor Antigen Derived From a Centrosome Residing Protein in Breast Carcinoma

(2009) Satoko Inoda et al.   JOURNAL OF IMMUNOTHERAPY

Molecular mechanisms of MHC class I abnormalities and APM components in human tumors

(2008) Barbara Seliger   CANCER IMMUNOLOGY IMMUNOTHERAPY

Epigenetic Enhancement of Antigen Processing and Presentation Promotes Immune Recognition of Tumors

(2008) A. F. Setiadi et al.   CANCER RESEARCH

Combining the Antigen Processing Components TAP and Tapasin Elicits Enhanced Tumor-Free Survival

(2008) Y. Lou et al.   CLINICAL CANCER RESEARCH

HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian Carcinoma

(2008) L. Y. Han et al.   CLINICAL CANCER RESEARCH

The quality control of MHC class I peptide loading

(2008) Pamela A Wearsch et al.   CURRENT OPINION IN CELL BIOLOGY